Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,256
Closed -$38K 566
2023
Q2
$38K Hold
1,256
0.01% 331
2023
Q1
$38.7K Hold
1,256
0.01% 279
2022
Q4
$47.2K Hold
1,256
0.01% 224
2022
Q3
$47K Sell
1,256
-890
-41% -$35.3K 0.02% 201
2022
Q2
$77K Buy
2,146
+1,144
+114% +$47.3K 0.03% 200
2022
Q1
$49K Hold
1,002
0.01% 248
2021
Q4
$48K Hold
1,002
0.01% 287
2021
Q3
$44K Hold
1,002
0.01% 278
2021
Q2
$44K Hold
1,002
0.02% 204
2021
Q1
$46K Hold
1,002
0.02% 248
2020
Q4
$32K Hold
1,002
0.01% 123
2020
Q3
$21K Hold
1,002
0.01% 120
2020
Q2
$21K Hold
1,002
0.01% 123
2020
Q1
$18K Hold
1,002
0.01% 157
2019
Q4
$39K Hold
1,002
0.02% 136
2019
Q3
$36K Hold
1,002
0.02% 118
2019
Q2
$35K Sell
1,002
-5,827
-85% -$203K 0.02% 147
2019
Q1
$235K Hold
6,829
0.17% 54
2018
Q4
$218K Sell
6,829
-4,171
-38% -$157K 0.14% 63
2018
Q3
$504K Buy
+11,000
New +$554K 0.35% 49

Other funds holding SNV

Arlington Partners's SNV Position: Q3 2023 in Review

Arlington Partners sold out of Synovus (SNV) in Q3 2023, closing a stake of 1,256 shares — an estimated $38K sold.

Arlington Partners first reported a position in SNV in Q3 2018 and held it in 20 quarters. The position peaked at $504K in Q3 2018. 371 funds tracked by Wall St. Rank hold SNV as of Q3 2023.

  • Arlington Partners reported no remaining Synovus position as of Q3 2023 after selling out during the quarter.
  • Arlington Partners sold 1,256 Synovus shares in Q3 2023, an estimated $38K.
  • Arlington Partners first reported a position in Synovus in Q3 2018 and held it in 20 quarters.
  • Arlington Partners's Synovus position peaked at $504K in Q3 2018.
  • 371 funds tracked by Wall St. Rank held Synovus as of Q3 2023.

Based on Arlington Partners's 13F filing for Q3 2023, filed 24 Oct 2023.